AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

GSK acquired an experimental therapy from Chimagen Biosciences, paying $300 million upfront for the “T-cell engager” therapy, ...

The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...

GlaxoSmithKline was formerly called GlaxoWelcome before its merger with U.S. pharmaceutical company SmithKline Beecham in 2000. The combination has made GlaxoSmithKline the 6th largest ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Welford covers the Healthcare sector, focusing on stocks such as Sanofi, GlaxoSmithKline, and Novartis ... AstraZeneca (AZN) Company Description: A merger between Astra of Sweden and Zeneca Group of ...

It was the third largest pharma takeover of all time, surpassed only by the merger of Glaxo Wellcome and SmithKline Beecham in 2000 and Pfizer’s buyout of Warner Lambert. Those deals were worth ...

The interaction with GSK goes deeper, with Novartis and GSK announcing a merger of their OTC divisions to create a new joint venture which will be number one in the sector. This mirrors an earlier ...

Korro has one other potential financial advantage over Wave: It is developing its RNA edited therapies alone rather than having to share up to 80% of revenue with GlaxoSmithKline (GSK), with which ...

Merck & Co said on Thursday that weak sales of Gardasil in China are likely to carry over into 2025 as the vaccine's distributor there reduces inventories amid low demand, and the U.S. drugmaker's ...

Global stock markets hold their breath as a neck-and-neck US election race leaves the future uncertain. I'm not taking any ...

The investor reportedly thinks the company’s stocks are underperforming relative to its peers, which include GSK’s Haleon spinout ... argued against the merger, which closed later that year ...